190 related articles for article (PubMed ID: 31968537)
1. 5,6-Dichloro-2-phenyl-benzotriazoles: New Potent Inhibitors of Orthohantavirus.
Sanna G; Piras S; Madeddu S; Busonera B; Klempa B; Corona P; Ibba R; Murineddu G; Carta A; Loddo R
Viruses; 2020 Jan; 12(1):. PubMed ID: 31968537
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.
Chung DH; Kumarapperuma SC; Sun Y; Li Q; Chu YK; Arterburn JB; Parker WB; Smith J; Spik K; Ramanathan HN; Schmaljohn CS; Jonsson CB
Antiviral Res; 2008 Jul; 79(1):19-27. PubMed ID: 18394724
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activity of ribavirin against Andes virus infection.
Safronetz D; Haddock E; Feldmann F; Ebihara H; Feldmann H
PLoS One; 2011; 6(8):e23560. PubMed ID: 21853152
[TBL] [Abstract][Full Text] [Related]
4. Maporal virus as a surrogate for pathogenic New World hantaviruses and its inhibition by favipiravir.
Buys KK; Jung KH; Smee DF; Furuta Y; Gowen BB
Antivir Chem Chemother; 2011 May; 21(5):193-200. PubMed ID: 21566265
[TBL] [Abstract][Full Text] [Related]
5. In-cell Western assay to quantify infection with pathogenic orthohantavirus Puumala virus in replication kinetics and antiviral drug testing.
Nusshag C; Schreiber P; Uhrig J; Zeier M; Krautkrämer E
Virus Res; 2023 Nov; 337():199230. PubMed ID: 37777116
[TBL] [Abstract][Full Text] [Related]
6. Development of a Comparative European Orthohantavirus Microneutralization Assay With Multi- Species Validation and Evaluation in a Human Diagnostic Cohort.
Hoornweg TE; Zutt I; de Vries A; Maas M; Hoogerwerf MN; Avšič-Županc T; Korva M; Reimerink JHJ; Reusken CBEM
Front Cell Infect Microbiol; 2020; 10():580478. PubMed ID: 33415084
[TBL] [Abstract][Full Text] [Related]
7. Development of small-molecule inhibitors against hantaviruses.
Deng X; Tian S; Yu Z; Wang L; Liang R; Li Y; Xiang R; Jiang S; Ying T; Yu F
Microbes Infect; 2020; 22(6-7):272-277. PubMed ID: 32445882
[TBL] [Abstract][Full Text] [Related]
8. Global Comprehensive Outlook of Hantavirus Contagion on Humans: A Review.
Ashique S; Sandhu NK; Das S; Haque SN; Koley K
Infect Disord Drug Targets; 2022; 22(3):e050122199975. PubMed ID: 34986775
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus.
Murphy ME; Kariwa H; Mizutani T; Yoshimatsu K; Arikawa J; Takashima I
Arch Virol; 2000; 145(8):1571-82. PubMed ID: 11003470
[TBL] [Abstract][Full Text] [Related]
10. Progress on the Prevention and Treatment of Hantavirus Disease.
Brocato RL; Hooper JW
Viruses; 2019 Jul; 11(7):. PubMed ID: 31277410
[TBL] [Abstract][Full Text] [Related]
11. Innate Immunity to Orthohantaviruses: Could Divergent Immune Interactions Explain Host-specific Disease Outcomes?
Kell AM
J Mol Biol; 2022 Mar; 434(6):167230. PubMed ID: 34487792
[TBL] [Abstract][Full Text] [Related]
12. A chemiluminescence detection method of hantaviral antigens in neutralisation assays and inhibitor studies.
Heider H; Ziaja B; Priemer C; Lundkvist A; Neyts J; Krüger DH; Ulrich R
J Virol Methods; 2001 Jul; 96(1):17-23. PubMed ID: 11516485
[TBL] [Abstract][Full Text] [Related]
13. Screening and identification of HTNV
Wen X; Zhang L; Liu Q; Xiao X; Huang W; Wang Y
Virol Sin; 2022 Aug; 37(4):531-537. PubMed ID: 35513270
[TBL] [Abstract][Full Text] [Related]
14. Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus.
Murphy ME; Kariwa H; Mizutani T; Tanabe H; Yoshimatsu K; Arikawa J; Takashima I
J Vet Med Sci; 2001 Jun; 63(6):637-45. PubMed ID: 11459009
[TBL] [Abstract][Full Text] [Related]
15. Antiviral effect of human saliva against hantavirus.
Hardestam J; Petterson L; Ahlm C; Evander M; Lundkvist A; Klingström J
J Med Virol; 2008 Dec; 80(12):2122-6. PubMed ID: 19040288
[TBL] [Abstract][Full Text] [Related]
16. Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors.
Piras S; Sanna G; Carta A; Corona P; Ibba R; Loddo R; Madeddu S; Caria P; Aulic S; Laurini E; Fermeglia M; Pricl S
Front Chem; 2019; 7():247. PubMed ID: 31041309
[TBL] [Abstract][Full Text] [Related]
17. A High-Throughput Flow Cytometry Screen Identifies Molecules That Inhibit Hantavirus Cell Entry.
Buranda T; Gineste C; Wu Y; Bondu V; Perez D; Lake KR; Edwards BS; Sklar LA
SLAS Discov; 2018 Aug; 23(7):634-645. PubMed ID: 29608398
[TBL] [Abstract][Full Text] [Related]
18. [Hantavirus infections].
Stock I
Med Monatsschr Pharm; 2008 Apr; 31(4):127-36; quiz 137-8. PubMed ID: 18497244
[TBL] [Abstract][Full Text] [Related]
19. [The new-world hantaviruses. Ecology and epidemiology of an emerging virus in Latin America].
Puerta H; Cantillo C; Mills J; Hjelle B; Salazar-Bravo J; Mattar S
Medicina (B Aires); 2006; 66(4):343-56. PubMed ID: 16977974
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
